Macquarie Group
COLL icon

Macquarie Group’s Collegium Pharmaceutical COLL Stock Holding History

Macquarie Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-282
Closed -$8.42K – 1666
2025
Q1 		$8.42K Buy
+282
New +$8.62K ﹤0.01% 1654
2022
Q3 		– Sell
-292
Closed -$5.15K – 2440
2022
Q2 		$5K Hold
292
– – ﹤0.01% 2519
2022
Q1 		$6 Hold
292
– – ﹤0.01% 2569
2021
Q4 		$5K Hold
292
– – ﹤0.01% 2571
2021
Q3 		$6K Hold
292
– – ﹤0.01% 2589
2021
Q2 		$7K Hold
292
– – ﹤0.01% 2498
2021
Q1 		$7K Sell
292
-139
-32% -$3.3K ﹤0.01% 2423
2020
Q4 		$9K Hold
431
– – ﹤0.01% 2311
2020
Q3 		$9K Hold
431
– – ﹤0.01% 2290
2020
Q2 		$8K Buy
+431
New +$8.44K ﹤0.01% 2310
2019
Q3 		– Sell
-497,011
Closed -$6.54M – 1896
2019
Q2 		$6.54M Sell
497,011
-1,914,707
-79% -$25.6M 0.01% 703
2019
Q1 		$36.5M Sell
2,411,718
-347,289
-13% -$5.56M 0.06% 327
2018
Q4 		$47.4M Buy
2,759,007
+221,779
+9% +$3.79M 0.09% 223
2018
Q3 		$37.4M Sell
2,537,228
-51,128
-2% -$906K 0.06% 329
2018
Q2 		$61.7M Buy
2,588,356
+233,598
+10% +$5.74M 0.11% 178
2018
Q1 		$60.2M Buy
2,354,758
+738,641
+46% +$17.6M 0.11% 176
2017
Q4 		$29.8M Buy
1,616,117
+286,138
+22% +$4.1M 0.05% 373
2017
Q3 		$14M Buy
1,329,979
+211,288
+19% +$2.33M 0.03% 543
2017
Q2 		$14M Buy
1,118,691
+302,892
+37% +$2.99M 0.03% 532
2017
Q1 		$8.21M Buy
815,799
+807,623
+9,878% +$12M 0.01% 647
2016
Q4 		$127K Buy
+8,176
New +$136K ﹤0.01% 1476
2016
Q2 		– Sell
-30,353
Closed -$551K – 1580
2016
Q1 		$551K Buy
+30,353
New +$552K ﹤0.01% 1220

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group's COLL Position: Q2 2025 in Review

Macquarie Group sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 282 shares — an estimated $8.42K sold.

Macquarie Group first reported a position in COLL in Q1 2016 and held it in 22 quarters. The position peaked at $61.7M in Q2 2018. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

  • Macquarie Group reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Macquarie Group sold 282 Collegium Pharmaceutical shares in Q2 2025, an estimated $8.42K.
  • Macquarie Group first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 22 quarters.
  • Macquarie Group's Collegium Pharmaceutical position peaked at $61.7M in Q2 2018.
  • 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.